Fundz

Neumora Therapeutics Names Joshua Pinto, Ph.D. as Chief Executive Officer

PUBLIC · NMRAAug 14, 2026

Position

Chief Executive Officer

Company

Neumora

Joshua Pinto, Ph.D.
WatertownBiotechnologyHealth CareTherapeuticsBiotechnology Research

Description

Neumora Therapeutics announced the appointment of Joshua Pinto, Ph.D. as CEO effective August 14, 2026, following Paul L. Berns' shift to Executive Chairperson

Who to call at Neumora, and when

A new leader at Neumora brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Neumora raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neumora, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neumora

Location

490 Arsenal Way, Suite 200

Watertown, Massachusetts, United States

About

Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people. However, treatments for many of the most prevalent brain disorders have been dominated by a single class of drugs, such as serotonin targeting antidepressants for MDD, leaving patients with a high degree of unmet medical need given the lack of diverse treatment options and mechanisms of action. We are taking a fundamentally different approach to the way treatments for brain diseases are developed. Our pipeline is comprised of programs pursuing therapeutically relevant targets implicated in Central Nervous System (CNS) diseases, each targeting a novel mechanism of action with best-in-class pharmacology. Our work is supported by our Precision Toolbox, which integrates a suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora is relentless in its commitment to discovering, developing and commercializing novel therapies for the 1.5 billion people living with brain diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neumora changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Henry
Likely contact at this company
••••••••@••••••••

See Henry's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Neumora's next move

Learn about Strategic plan

Neumora changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.